← Back to headlines
Telix Pharmaceuticals Misses EPS and Revenue Estimates
Telix Pharmaceuticals reported a GAAP EPS of -$2.11, missing estimates by $2.14, with revenue of $803.8 million also falling short by $22.79 million.
19 Feb, 22:52 — 19 Feb, 22:52
